Results 71 to 80 of about 15,580,988 (193)
SPG4 and Dementia: Expanding the Clinical Spectrum
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
Hereditary spastic paraplegia (HSP) is a group of disorders characterized by progressive spasticity and lower limb weakness, with mutations in SPG4/SPAST being the most common cause. Detailed studies and clinical and molecular comparisons across different populations are missing.Emanuele Panza, Arun Meyyazhagan, Eliseo Picchi, Gustavo Ribas, Ingrid Faber, Ryosuke Miyamoto, Preethi Basavaraju, Paolo Eusebi, Haripriya Kuchi Bhotla, Mario Stasi, Fabrizio Gaudiello, Francesco Patti, Filippo Maria Santorelli, Marcondes Cavalcante França Jr, José Luiz Pedroso, Orlando Graziani Povoas Barsottini, Hélio Afonso Ghizoni Teive, Peter Henry St George‐Hyslop, Toshitaka Kawarai, Antonio Orlacchio +19 morewiley +1 more sourceRNA Sequencing Resolves Cryptic Pathogenic Variants in Mitochondrial Disease
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
Mitochondrial diseases are the most common inherited metabolic disorders, characterized by pronounced clinical and genetic heterogeneity that complicates molecular diagnosis. Although DNA‐based sequencing approaches have become standard in genetic testing, up to half of patients remain without a definitive diagnosis.Zhimei Liu, Xin Duan, Fatemeh Peymani, Jia Wang, Chengjia Bao, Chaolong Xu, Ying Zou, Zixuan Zhang, Yunxi Zhang, Tongyue Li, Martin Pavlov, Junling Wang, Minhan Song, Tianyu Song, Xiaodi Han, Mingxi Sun, Danmin Shen, Ruoyu Duan, Huafang Jiang, Manting Xu, Holger Prokisch, Fang Fang +21 morewiley +1 more sourcePredictive Ability of Plasma p‐tau217 for β‐Amyloid Status: A Prospective Multicenter Study
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
Plasma tau phosphorylated at threonine 217 (p‐tau217) measured with fully automated platforms has shown high accuracy for Alzheimer's disease (AD) diagnosis, but real‐world multicenter data remain limited. We aimed to validate the diagnostic performance of p‐tau217 for identifying AD pathology in a real‐world multicenter cohort ...Miquel Massons, Nuria Guillen, Jordi Sarto, Neus Falgàs, Sergi Borrego‐Écija, Diana Esteller‐Gauxax, Magda Castellví, Adrià Tort‐Merino, Agnès Pérez‐Millan, Anna Antonell, Josep M. Augè Fradera, Gerard Piñol, Iolanda Riba, Anna Carnes‐Vendrell, Marta Cullell, Maria Teresa Osuna, Lorena Bajo, Teresa Romero, Eva Bonjoch, Joan Bello, Susana Fernández, Marta Balagué, Isabel Gómez‐Ruiz, Anuncia Boltes, Claustre Pont, Raquel Cuevas, Sara Carrillo, Laura Iglesias, Teresa Maria Casadevall Codina, Lorena Grau Guinea, Fernando Jose Espada, Raquel Sánchez‐Valle, Mircea Balasa, Albert Lladó +33 morewiley +1 more sourceAdded Prognostic Value of EEG Reactivity in Comatose Patients Following Cardiac Arrest
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objectives
To evaluate the added prognostic value of EEG reactivity for favorable outcome compared with background analysis during and after targeted temperature management (TTM). Methods
Prospective observational cohort study of comatose post–cardiac arrest patients admitted to a single academic center between 2017 and 2022, all undergoing ...Sarah Caroyer, Marie Obrecht, Charlotte de Maeseneire, Charlotte Damien, Chantal Depondt, Lorenzo Ferlini, Estelle Rikir, Filippo Annoni, Fabio Silvio Taccone, Nicolas Mavroudakis, Benjamin Legros, Nicolas Gaspard +11 morewiley +1 more sourceUnderstanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised Clustering
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background
Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.Bade Gulec, Elif Everest, Melih Tutuncu, Ugur Bilge, Sabahattin Saip, Ugur Uygunoglu, Aksel Siva +6 morewiley +1 more sourceDimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.F. Shawket, J. Lycke, J. Salzer, F. Piehl, K. Fink, N. Lange, J. Mellergård, C. Malmeström, P. Sundström, I. Erngren, A. al‐Grety, E. Freyhult, K. Kultima, J. Burman, A. Svenningsson +14 morewiley +1 more sourceFirst $^{94}$Nb($n,γ$) Measurement: Constraining the Nucleosynthetic Origin of $^{94}$Mo in Presolar Grains
International audienceIsotopic measurements of presolar silicon carbide grains from dying stars have revealed a puzzling overabundance of $^{94}$Mo that stellar nucleosynthesis models have failed to reproduce for two decades.Bosnar, D, Di Maria, S, Hillman, W, Tarifeño-Saldivia, A, Dellmann, S.F, Boromiza, M, Vecchio, G, Rubbia, C, Petrone, C, Alcayne, V, Amaducci, S, Sosnin, N.V, Valenta, S, Musumarra, A, Lerendegui-Marco, J, Krtička, M, ˇ, P. Zugec, Pérez-Maroto, P, Gustavino, C, Kopatch, Y, Vlachoudis, V, Dupont, E, Manna, A, del Olmo, J. Plaza, Berthoumieux, E, Lederer-Woods, C, Mastinu, P, Bennett, S, Romanets, Y, González, E. Musacchio, Sturniolo, A, Tagliente, G, Cano-Ott, D, Lerner, G, Vescovi, D, Porras, I, Andrzejewski, J, Domingo-Pardo, C, Fiore, S, Wallner, A, Colombetti, P, Jericha, E, Aberle, O, de Rada Fiol, A. Pérez, Altieri, S, Masi, A, Bacak, M, Eleme, Z, Pellegriti, M.G, Schumann, D, Liu, N, Colonna, N, Babiano-Suarez, V, Kimura, A, Gawlik-Ramikega, A, Cortés, G, Calviño, F, Gervino, G, Furman, V, Patronis, N, Cristallo, S, Woods, P.J, Torres-Sánchez, P, Durán, I, Kokkoris, M, Urlass, S, Finocchiaro, P, Dressler, R, Chiaveri, E, Heyse, J, Sánchez-Caballero, A, Cerutti, F, Reifarth, R, Chasapoglou, S, Diakaki, M, Cosentino, L, Mengoni, A, Smith, A.G, Maugeri, E.A, Bernardes, A.P, Di Castro, M, Quesada, J.M, Gunsing, F, Kaur, G, Dietz, M, García-Infantes, F, Gilardoni, S, Massimi, C, Cescutti, G, Pomp, S, Milazzo, P.M, Martínez, T, Mastromarco, M, Calviani, M, Murtas, F, Tarrío, D, Caamaño, M, Guerrero, C, Perkowski, J, Kaperoni, K, Kadi, Y, Castelluccio, D.M, Vaz, P, Mazzone, A, González-Romero, E, Wright, T, Schillebeeckx, P, Mendoza, E, Variale, V, Cortés-Giraldo, M.A, Vlastou, R, Fargier, S, Praena, J, Michalopoulou, V, Sekhar, A, Beltrami, C, Ladarescu, I, Fernández-Domínguez, B, Junghans, A, Pirovano, E, Balibrea-Correa, J, Rochman, D, Zarrella, R, Negret, A, Mönch, I, Mucciola, R, Knapová, I, Jenkins, D.G, Pavón, J.A, Vagena, E, Kyritsis, N, Camprini, P. Console, Fernández, B, Köster, U, Stamati, M.E, Beyer, R, Casanovas, A, Sabaté-Gilarte, M +137 morecore +1 more sourceProdromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker‐Defined Synucleinopathy
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
Isolated rapid eye movement sleep behavior disorder (iRBD) is a prodromal state for Lewy body disorders and exhibits biological heterogeneity that may influence clinical expression and progression. We examined clinical features in individuals with iRBD and biomarker‐defined synucleinopathy.Daniel Weintraub, Michele K. York, Roseanne Dobkin, Anuprita R. Nair, Ryan Kurth, David‐Erick Lafontant, Chelsea Caspell‐Garcia, Roy N. Alcalay, Ethan G. Brown, Lana M. Chahine, Christopher Coffey, Tatiana Foroud, Douglas Galasko, Karl Kieburtz, Kenneth Marek, Kalpana Merchant, Brit Mollenhauer, Kathleen L. Poston, Andrew Siderowf, Cristina Simonet, Tanya Simuni, Caroline M. Tanner, Thomas F. Tropea, Aleksandar Videnovic, The Parkinson's Progression Markers Initiative +24 morewiley +1 more sourceRisk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP‐1 Receptor Agonists
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Introduction
Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.Faisal A. Al‐Harbi, Mohanad A. Alkuwaiti, Yazeed B. Alaql, Ahmed K. Alsaif, Ahmed A. Alessa, Meshari Ayed Alharbi, Mohammed Alfalah, Saud A. Alnaaim, Sajjad M. AlHaddad, Ahmed Y. Azzam +9 morewiley +1 more source